Christoph Hanski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christoph Hanski has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Martin Zeitz
Department of Gastroenterology, Charité, Campus Benjamin Franklin, Berlin, Germany
2 shared publicationsB F Gillissen
Department of Gastroenterology, Charité-Universitaetsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
1 shared publicationB. Choudhary
Medizinische Klinik I, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
1 shared publicationBritta Jebautzke
Department of Gastroenterology, Charité, Campus Benjamin Franklin, Berlin, Germany
1 shared publicationC. Loddenkemper
Institut für Pathologie, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
1 shared publicationChristoph Loddenkemper
Institut für Pathologie, Charité Campus Benjamin Franklin, Berlin, Germany
1 shared publication
Latest Publications
- Open Access
- 29 July 2011
- Published by Wiley in International Journal of Cancer
- Vol. 130 (12) , 2771-2782
UDCA slows down intestinal cell proliferation by inducing high and sustained ERK phosphorylation
Ursodeoxycholic acid (UDCA) attenuates colon carcinogenesis in humans and in animal models by an unknown mechanism. We investigated UDCA effects on normal intestinal epithelium in vivo and in vitro to identify the potential chemopreventive mechanism. Feeding of mice with 0.4% UDCA reduced cell proliferation to 50% and suppressed several potential proproliferatory genes including insulin receptor substrate 1 (Irs‐1). A similar transcriptional response was observed in the rat intestinal cell line IEC‐6 which was then used as an in vitro model. UDCA slowed down the proliferation of IEC‐6 cells and induced sustained hyperphosphorylation of ERK1/ERK2 kinases which completely inhibited the proproliferatory effects of EGF and IGF‐1. The hyperphosphorylation of ERK1 led to a transcriptional suppression of the Irs‐1 gene. Both, the hyperphosphorylation of ERK as well as the suppression of Irs‐1 were sufficient to inhibit proliferation of IEC‐6 cells. ERK1/ERK2 inhibition in vitro or ERK1 elimination in vitro or in vivo abrogated the antiproliferatory effects of UDCA. We show that UDCA inhibits proliferation of nontransformed intestinal epithelial cells by inducing a sustained hyperphosphorylation of ERK1 kinase which slows down the cell cycle and reduces expression of Irs‐1 protein. These data extend our understanding of the physiological and potentially chemopreventive effects of UDCA and identify new targets for chemoprevention.
- 29 July 2011
- Published by Wiley in International Journal of Cancer
- Vol. 130 (12) , 2771-2782
Open AccessUDCA slows down intestinal cell proliferation by inducing high and sustained ERK phosphorylation
Ursodeoxycholic acid (UDCA) attenuates colon carcinogenesis in humans and in animal models by an unknown mechanism. We investigated UDCA effects on normal intestinal epithelium in vivo and in vitro to identify the potential chemopreventive mechanism. Feeding of mice with 0.4% UDCA reduced cell proliferation to 50% and suppressed several potential proproliferatory genes including insulin receptor substrate 1 (Irs‐1). A similar transcriptional response was observed in the rat intestinal cell line IEC‐6 which was then used as an in vitro model. UDCA slowed down the proliferation of IEC‐6 cells and induced sustained hyperphosphorylation of ERK1/ERK2 kinases which completely inhibited the proproliferatory effects of EGF and IGF‐1. The hyperphosphorylation of ERK1 led to a transcriptional suppression of the Irs‐1 gene. Both, the hyperphosphorylation of ERK as well as the suppression of Irs‐1 were sufficient to inhibit proliferation of IEC‐6 cells. ERK1/ERK2 inhibition in vitro or ERK1 elimination in vitro or in vivo abrogated the antiproliferatory effects of UDCA. We show that UDCA inhibits proliferation of nontransformed intestinal epithelial cells by inducing a sustained hyperphosphorylation of ERK1 kinase which slows down the cell cycle and reduces expression of Irs‐1 protein. These data extend our understanding of the physiological and potentially chemopreventive effects of UDCA and identify new targets for chemoprevention.
- Open Access
- 9 April 2010
- Published by Wiley in International Journal of Cancer
- Vol. 126 (12) , 2813-2825
Mismatch repair system decreases cell survival by stabilizing the tetraploid G1 arrest in response to SN‐38
The role of the mismatch repair (MMR) system in correcting base–base mismatches is well established; its involvement in the response to DNA double strand breaks, however, is less clear. We investigated the influence of the essential component of MMR, the hMLH1 protein, on the cellular response to DNA‐double strand breaks induced by treatment with SN‐38, the active metabolite of topoisomerase I inhibitor irinotecan, in a strictly isogenic cell system (p53wt, hMLH1+/p53wt, hMLH1−). By using hMLH1 expressing clones or cells transduced with the hMLH1‐expressing adenovirus as well as siRNA technology, we show that in response to SN‐38‐induced DNA damage the MMR proficient (MMR+) cells make: (i ) a stronger G2/M arrest, (ii ) a subsequent longer tetraploid G1 arrest, (iii ) a stronger activation of Chk1 and Chk2 kinases than the MMR deficient (MMR−) counterparts. Both Cdk2 and Cdk4 kinases contribute to the basal tetraploid G1 arrest in MMR+ and MMR− cells. Although the Chk1 kinase is involved in the G2/M arrest, neither Chk1 nor Chk2 are involved in the enhancement of the tetraploid G1 arrest. The long‐lasting tetraploid G1 arrest of MMR+ cells is associated with their lower clonogenic survival after SN‐38 treatment, the abrogation of the tetraploid G1 arrest resulted in their better clonogenic survival. These data show that the stabilization of the tetraploid G1 arrest in response to double strand breaks is a novel function of the MMR system that contributes to the lesser survival of MMR+ cells.
- 9 April 2010
- Published by Wiley in International Journal of Cancer
- Vol. 126 (12) , 2813-2825
Open AccessMismatch repair system decreases cell survival by stabilizing the tetraploid G1 arrest in response to SN‐38
The role of the mismatch repair (MMR) system in correcting base–base mismatches is well established; its involvement in the response to DNA double strand breaks, however, is less clear. We investigated the influence of the essential component of MMR, the hMLH1 protein, on the cellular response to DNA‐double strand breaks induced by treatment with SN‐38, the active metabolite of topoisomerase I inhibitor irinotecan, in a strictly isogenic cell system (p53wt, hMLH1+/p53wt, hMLH1−). By using hMLH1 expressing clones or cells transduced with the hMLH1‐expressing adenovirus as well as siRNA technology, we show that in response to SN‐38‐induced DNA damage the MMR proficient (MMR+) cells make: (i ) a stronger G2/M arrest, (ii ) a subsequent longer tetraploid G1 arrest, (iii ) a stronger activation of Chk1 and Chk2 kinases than the MMR deficient (MMR−) counterparts. Both Cdk2 and Cdk4 kinases contribute to the basal tetraploid G1 arrest in MMR+ and MMR− cells. Although the Chk1 kinase is involved in the G2/M arrest, neither Chk1 nor Chk2 are involved in the enhancement of the tetraploid G1 arrest. The long‐lasting tetraploid G1 arrest of MMR+ cells is associated with their lower clonogenic survival after SN‐38 treatment, the abrogation of the tetraploid G1 arrest resulted in their better clonogenic survival. These data show that the stabilization of the tetraploid G1 arrest in response to double strand breaks is a novel function of the MMR system that contributes to the lesser survival of MMR+ cells.
- Open Access
- 14 March 2006
- Published by Wiley in International Journal of Cancer
- Vol. 118 (11) , 2750-2757
Prevention of colitis‐associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid
Bile acids in the intestinal lumen contribute to the homeostatic regulation of proliferation and death of the colonic epithelial cells: Deoxycholic acid (DCA) appears to enhance and ursodeoxycholic acid (UDCA) to attenuate the process of chemically induced carcinogenesis. We studied the effects of UDCA on colitis‐related colorectal carcinogenesis. Three groups of 25 mice were given 0.7% dextran sulphate in drinking water for 7 days and pure water for 10 days and were fed a standard diet containing double iron concentration. In 2 groups, the diet was supplemented with 0.2% cholic acid (CA), the precursor of DCA, or with 0.4% UDCA. After 15 cycles, the histology, the expression of MUC2, β‐catenin, p27 and p16 and the fecal water concentration of DCA and UDCA were investigated. All animals showed colitis with similar severity and histologic as well as immunophenotypic alterations, resembling those of human colitis. Among the animals fed the nonsupplemented diet, 46% developed colorectal adenocarcinomas and 54% anal‐rectal squamous cell carcinomas. The prevalence of dysplasia and carcinomas did not change significantly in the animals given CA. Among the mice fed with UDCA, none developed adenocarcinomas and 20% squamous carcinomas. Dysplastic lesions were found in 88%, 67% and 40% of each group, respectively. The prevalence of dysplasia as well as of carcinoma showed an inverse relationship to the UDCA concentration in the fecal water. These data indicate that UDCA suppresses colitis‐associated carcinogenesis. This model is suitable for investigation of the mechanism of the anticarcinogenic effect of UDCA in vivo.
- 14 March 2006
- Published by Wiley in International Journal of Cancer
- Vol. 118 (11) , 2750-2757
Open AccessPrevention of colitis‐associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid
Bile acids in the intestinal lumen contribute to the homeostatic regulation of proliferation and death of the colonic epithelial cells: Deoxycholic acid (DCA) appears to enhance and ursodeoxycholic acid (UDCA) to attenuate the process of chemically induced carcinogenesis. We studied the effects of UDCA on colitis‐related colorectal carcinogenesis. Three groups of 25 mice were given 0.7% dextran sulphate in drinking water for 7 days and pure water for 10 days and were fed a standard diet containing double iron concentration. In 2 groups, the diet was supplemented with 0.2% cholic acid (CA), the precursor of DCA, or with 0.4% UDCA. After 15 cycles, the histology, the expression of MUC2, β‐catenin, p27 and p16 and the fecal water concentration of DCA and UDCA were investigated. All animals showed colitis with similar severity and histologic as well as immunophenotypic alterations, resembling those of human colitis. Among the animals fed the nonsupplemented diet, 46% developed colorectal adenocarcinomas and 54% anal‐rectal squamous cell carcinomas. The prevalence of dysplasia and carcinomas did not change significantly in the animals given CA. Among the mice fed with UDCA, none developed adenocarcinomas and 20% squamous carcinomas. Dysplastic lesions were found in 88%, 67% and 40% of each group, respectively. The prevalence of dysplasia as well as of carcinoma showed an inverse relationship to the UDCA concentration in the fecal water. These data indicate that UDCA suppresses colitis‐associated carcinogenesis. This model is suitable for investigation of the mechanism of the anticarcinogenic effect of UDCA in vivo.
- 19 September 2005
- Published by Springer Nature in Oncogene
- Vol. 25 (2) , 165-175
Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth
Knowledge of the type of biological reaction to chemotherapy is a prerequisite for its rational enhancement. We previously showed that irinotecan-induced DNA damage triggers in the HCT116p53wt colon carcinoma cell line a long-term cell cycle arrest and in HCT116p53-/- cells apoptosis (Magrini et al., 2002). To compare the contribution of long-term cell cycle arrest and that of apoptosis to inhibition of cell proliferation after irinotecan-induced DNA damage, we used this isogenic system as well as the cell lines LS174T (p53wt) and HT-29 (p53mut). Both p53wt cell lines responded to damage by undergoing a long-term tetraploid G1 arrest, whereas the p53mut cell lines underwent apoptosis. Cell cycle arrest as well as apoptosis caused a similar delay in cell proliferation. Irinotecan treatment also induced in mouse tumours derived from the p53wt cell lines a tetraploid G1 arrest and in those derived from the p53-deficient cell lines a transient G2/M arrest and apoptosis. The delay of tumour growth was in the same range in both groups, that is, arrest- and apoptosis-mediated tumour growth inhibition was comparable. In conclusion, cell cycle arrest as well as apoptosis may be equipotent mechanisms mediating the chemotherapeutic effects of irinotecan.
- 19 September 2005
- Published by Springer Nature in Oncogene
- Vol. 25 (2) , 165-175
Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth
Knowledge of the type of biological reaction to chemotherapy is a prerequisite for its rational enhancement. We previously showed that irinotecan-induced DNA damage triggers in the HCT116p53wt colon carcinoma cell line a long-term cell cycle arrest and in HCT116p53-/- cells apoptosis (Magrini et al., 2002). To compare the contribution of long-term cell cycle arrest and that of apoptosis to inhibition of cell proliferation after irinotecan-induced DNA damage, we used this isogenic system as well as the cell lines LS174T (p53wt) and HT-29 (p53mut). Both p53wt cell lines responded to damage by undergoing a long-term tetraploid G1 arrest, whereas the p53mut cell lines underwent apoptosis. Cell cycle arrest as well as apoptosis caused a similar delay in cell proliferation. Irinotecan treatment also induced in mouse tumours derived from the p53wt cell lines a tetraploid G1 arrest and in those derived from the p53-deficient cell lines a transient G2/M arrest and apoptosis. The delay of tumour growth was in the same range in both groups, that is, arrest- and apoptosis-mediated tumour growth inhibition was comparable. In conclusion, cell cycle arrest as well as apoptosis may be equipotent mechanisms mediating the chemotherapeutic effects of irinotecan.